NCT00410033View on ClinicalTrials.gov

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

NACompletedINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

December 31, 1989

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

soluble human insulin

DRUG

isophane human insulin

DRUG

insulin aspart

Trial Locations (1)

581 85

Novo Nordisk Investigational Site, Linköping

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY